Kato, Tetsuya
*Department of Immunology, Graduate School of Pharmaceutical Sciences and
2 papers on CoChat
Most cited papers
- Verified
Discovery of the First Potent and Selective Small Molecule Opioid Receptor-like (ORL1) Antagonist: 1-[(3 R,4 R)-1-Cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl- 1,3-dihydro-2 H-benzimidazol-2-one (J-113397)
Kawamoto, H., Ozaki, S., Itoh, Y., Miyaji, M., Arai, S., Nakashima, H., Kato, T., Ohta, H., & Iwasawa, Y. (1999) · Journal of Medicinal Chemistry
Neuropeptides and Animal PhysiologyReceptor Mechanisms and Signaling
Cited by 204
- Verified
Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice
Tsujikawa, K., Yayama, K., Hayashi, T., Matsushita, H., Yamaguchi, T., Shigeno, T., Ogitani, Y., Hirayama, M., Kato, T., Fukada, S.-I., et al. (2007) · Proceedings of the National Academy of Sciences
Neuropeptides and Animal PhysiologyCardiovascular, Neuropeptides, and Oxidative Stress Research
Cited by 136
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free